Address: Akpınar Mah. Osmangazi Cad. No:156
Sancaktepe / ISTANBUL / TURKEY
Tel: 0216 398 10 63
Biofarma, one of the most rooted medicine firms of our country with foundations back to 1945, carried out its activities in Mercan district of Istanbul between 1950 and 1989.
Biofarma, which has been purchased by Pharmacist Mustafa ÖNCEL and then turned into Limited Company in 1973, has always been a part of attempts and developments then required with its technological possibilities and expert staff in terms of human drug production. Biofarma has been moved in 1990 from its facilities in Mercan-Istanbul, where it was first established, to the modern facilities with an area of 15.000 m2 on a land of 17.000 m2, and has been turned into a joint stock company in 1998. Today, it is a part of Partners in Life Sciences (PILS) and Citigroup Venture Capital International (CVCI).
Our mission as Biofarma is to produce quality generic drugs at world standards (cGXP) with a respect of environment and awareness of social responsibility.
Our vision as Biofarma is to take part among the global generic drug manufacturers and to make our products available in all world countries.
Allergy / Immunology
CNS / Neurology
Dentistry / Oral
Endocrinology / Metabolics
Gastrointestinal & Hepatology
Gerontology / Aging
Obstetrics / Gynecology
Oncology / Hematology
Respiratory / Pulmonary
Rheumatology / Arthritis
Vitamins and Minerals
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country.…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over…
As the international community continues its quest to vaccinate the global population against COVID-19, shortages…
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD),…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…